搜索临床试验以:ACP-196(acalabrutinib)
总计8194个结果
-
Groupe Hospitalier Paris Saint JosephObvioHealth完全的
-
Jordan University of Science and TechnologyScientific Research Fund, Ministry of Higher Education and Research, Jordan完全的
-
OHSU Knight Cancer InstituteOregon Health and Science University; Incyte Corporation招聘中
-
Merck Sharp & Dohme LLC主动,不招人癌,肾细胞美国, 澳大利亚, 加拿大, 智利, 法国, 匈牙利, 以色列, 大韩民国, 荷兰, 新西兰, 波兰, 西班牙, 英国
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
RS MedicalAccelerated Care Plus; Research Institute of Health and Science (RIHSE)完全的
-
University of ArkansasNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Northwestern University 和其他合作者完全的
-
University Hospital, GhentGC Europe完全的
-
Seoul National University HospitalAsan Medical Center; Ulsan University Hospital; Korea University Anam Hospital; Ewha Womans University... 和其他合作者完全的
-
Ludwig Institute for Cancer ResearchWyeth is now a wholly owned subsidiary of Pfizer终止
-
Idorsia Pharmaceuticals Ltd.完全的
-
Dana-Farber Cancer InstituteNational Institute on Aging (NIA)完全的
-
Hospital for Special Surgery, New YorkOrthopedic Research and Education Foundation招聘中
-
Idorsia Pharmaceuticals Ltd.终止
-
Second Affiliated Hospital of Soochow UniversityShanghai Regenelead Therapies Co., Ltd.招聘中
-
National Cancer Institute (NCI)终止
-
Daiichi Sankyo, Inc.ICON Clinical Research; ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a...完全的
-
National Cancer Institute (NCI)完全的IV 期乳腺癌 | 复发性乳腺癌 | 雌激素受体阴性 | HER2/Neu 阴性 | 孕激素受体阴性 | 三阴性乳腺癌美国